Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Orasure Tech Inc (OSUR)

Orasure Tech Inc (OSUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
OraSure: Q4 Earnings Snapshot

OraSure: Q4 Earnings Snapshot

OSUR : 4.20 (-0.94%)
OraSure: Q3 Earnings Snapshot

OraSure: Q3 Earnings Snapshot

OSUR : 4.20 (-0.94%)
OraSure: Q2 Earnings Snapshot

OraSure: Q2 Earnings Snapshot

OSUR : 4.20 (-0.94%)
OraSure: Q1 Earnings Snapshot

OraSure: Q1 Earnings Snapshot

OSUR : 4.20 (-0.94%)
Why OraSure Technologies Stock Is Jumping Today

Investors applauded the diagnostics company's Q4 update.

OSUR : 4.20 (-0.94%)
OraSure: Q4 Earnings Snapshot

OraSure: Q4 Earnings Snapshot

OSUR : 4.20 (-0.94%)
OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year

InteliSwab® revenue of $43.1 million in Q2, up 95% sequentially with significant scaling in production InteliSwab® gross margins improve sequentially...

OSUR : 4.20 (-0.94%)
OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET

BETHLEHEM, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering...

OSUR : 4.20 (-0.94%)
OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack

Race to End Hep C initiative demonstrates the ability of easy-to-administer, low-cost testing solutions to identify patients and direct them to...

OSUR : 4.20 (-0.94%)
OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

BETHLEHEM, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing...

OSUR : 4.20 (-0.94%)

Barchart Exclusives

Should You Buy CrowdStrike Stock? Its Dip Make CRWD Appealing to Contrarians
Contrarians are now looking at CrowdStrike stock. The stock is down almost 22% after its software crash last week. However, its free cash flow is still strong. Put option premiums are now very high, ideal for short plays. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar